A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles
One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies
The Childhood Cancer Project raises $100,000 for childhood cancer research.
Blockchain Technology Improves Quality and Data Integrity of Ethical's eAdjudication® Software for Clinical Endpoint Adjudication
Wilber Z. Sine, MD to join Exemplar Research, Inc. as Principal Investigator - Expansion into CNS/Behavioral Health Clinical Study.
Florence announces over 2,000 clinical trial sites are now using Florence eBinders to accelerate studies with eRegulatory and eSource.
Support of discovery programs is essential to providing integrated drug development services. The key is to have the expertise to be able to tackle complex matrices along with any biomarker component.
The race is on for non-alcoholic steatohepatitis (NASH) drug development as the disease—which has no approved treatments—is rapidly growing in prevalence and is the fastest rising cause of liver transplantation in the United States.
Clemson University research finds adaptive sports/recreation therapy has positive mental health impact on veterans and their families
Patient engagement experts from Bracket and Boehringer-Ingelheim to discuss technology selection and implementation strategies for clinical trials.
Dr. Thomas Mosley will share the latest advances in Alzheimer's and dementia research occurring at UMMC's MIND Center during a free seminar at St. Catherine's Village in Madison, Mississippi on March 29 at 2:30 p.m.
Meeting to take place on Friday, April 6, 2018.
Flexible, Fast, Efficient: The Expanding Role of Single-Site PMA Approval in Companion Diagnostics Development
Presenters discuss how clinical innovators, Market Access, IT and HEOR can accelerate RWE initiatives and the implications for data security and healthcare decision-making